Along a similar line of evidence, the mono-ADP-ribosyltransferase PARP3 has been reported to positively regulate the Rictor/mTORC2 signalling in models of triple negative breast cancer. The gene discussed is PARP3; the disease is triple-negative breast carcinoma.